Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-20-000096
Filing Date
2020-04-30
Accepted
2020-04-30 16:41:46
Documents
81
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptct0331202010-q.htm   iXBRL 10-Q 1717834
2 EXHIBIT 10.1 bmssecondamendment.htm EX-10.1 47056
3 EXHIBIT 31.1 ptct03312020ex-311.htm EX-31.1 14378
4 EXHIBIT 31.2 ptct03312020ex-312.htm EX-31.2 14345
5 EXHIBIT 32.1 ptct03312020ex-321.htm EX-32.1 7332
6 EXHIBIT 32.2 ptct03312020ex-322.htm EX-32.2 7284
  Complete submission text file 0001070081-20-000096.txt   9811119

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200331.xsd EX-101.SCH 56855
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200331_cal.xml EX-101.CAL 89899
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200331_def.xml EX-101.DEF 466657
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200331_lab.xml EX-101.LAB 874202
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200331_pre.xml EX-101.PRE 615081
29 EXTRACTED XBRL INSTANCE DOCUMENT ptct0331202010-q_htm.xml XML 1771156
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 20836254
SIC: 2834 Pharmaceutical Preparations